{
    "2021-07-23": [
        [
            {
                "time": "",
                "original_text": "明星基金经理“减持”引市场“跟风”？生物疫苗龙头康泰生物连日大震荡 减持股份",
                "features": {
                    "keywords": [
                        "明星基金经理",
                        "减持",
                        "康泰生物",
                        "市场跟风",
                        "大震荡"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【预见】股东拟减持，康华生物（300841.SZ）如何应对“成长的烦恼”？ 拟减持股份",
                "features": {
                    "keywords": [
                        "股东减持",
                        "康华生物",
                        "成长烦恼"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：原股东的优先认购通过深交所系统进行，并按要求进行认购委托",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "优先认购",
                        "深交所"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物疫苗"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：新型冠状病毒灭活疫苗（Vero细胞）已经在國內纳入紧急使用，目前己进入广东省、江苏省、四川省、贵州省、湖北省、湖南省、河南省等",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "新冠疫苗",
                        "紧急使用",
                        "多省纳入"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：新冠灭活疫苗III期临床试验第一针接种预计2个月后获中期揭盲数据",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "新冠疫苗",
                        "III期临床",
                        "中期数据"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：截至2021年6月30日，公司共获得授权专利50项，包括肺炎类疫苗的专利",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "授权专利",
                        "肺炎疫苗"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：冻干人用狂犬病疫苗（人二倍体细胞）已按照新的《药品注册管理办法》申请药品注册批件",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "狂犬病疫苗",
                        "药品注册"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：公司半年度报告当前预约披露的时间为2021年8月30日",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "半年度报告",
                        "披露时间"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物疫苗"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：三胎支持政策出台 相关配套板块迎来机遇",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三胎政策",
                        "配套板块",
                        "机遇"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "13股中报估值大幅下降+股价上涨空间超30%",
                "features": {
                    "keywords": [
                        "中报估值",
                        "股价上涨",
                        "空间超30%"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "北向资金动向盘点：重手净买金融，大额净卖医药",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买金融",
                        "净卖医药"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}